University Hospital Tuebingen

This study is testing a new treatment approach for a very aggressive type of brain cancer called glioblastoma. The goal is to see if giving a higher dose of radiation, along with a drug (bevacizumab) meant to protect healthy tissue, can help patients live longer without causing s…

This study is testing whether precise, MRI-guided radiation treatment can help rectal cancer patients avoid major surgery to remove their rectum. The goal is to preserve normal bowel function while still effectively treating the cancer. Patients will receive this targeted radiati…

This study is testing if a specially designed diet can work as well as standard medications for improving quality of life during a Crohn's disease flare-up. It will compare the diet, which includes a nutritional drink, against usual drug treatments in 52 adults with active Crohn'…

This early-stage trial is testing a new personalized vaccine for patients with a rare liver cancer called fibrolamellar hepatocellular carcinoma (FLC). The vaccine is designed to teach the patient's own immune system to recognize and attack any remaining cancer cells after initia…

This study is testing a drug called tafasitamab in children and teenagers with a very high-risk form of B-cell leukemia that has come back or hasn't responded to standard treatments like stem cell transplants. The main goals are to find a safe dose and see if the drug can help pr…

This study is testing whether a cold plasma treatment can clear HPV infections in women. Researchers will treat 50 women with confirmed HPV infections and monitor whether the virus is eliminated. The study also aims to understand how the treatment affects cervical cells and tissu…

This study is testing a new AI tool designed to automatically detect surgical smoke during laparoscopic (keyhole) surgery. The tool watches the video feed from inside the patient's body and alerts the surgical team when smoke appears, which can block the surgeon's view. Researche…

This study is testing whether an 8-week group program called 'Healthy Under Stress' can help people feel less stressed. The program teaches mindfulness, relaxation, nutrition, and communication skills. Researchers will measure changes in stress, anxiety, depression, and quality o…

This study aims to understand why some patients experience heart injury during non-cardiac surgery. Researchers will observe 3,000 high-risk patients undergoing various surgeries to identify which anesthesia and surgical factors contribute to this risk. The findings will help dev…

This study aims to see if different types of surgeries create unique electrical signal patterns, like a digital 'fingerprint', when using standard surgical tools. Researchers will record these signals from 160 patients undergoing specific procedures to build a database. The goal …

This study aims to understand how stomach and digestive symptoms change for people with anorexia or bulimia during inpatient weight rehabilitation. Researchers will observe about 185 patients to see if their main diet type—flexitarian, vegetarian, or vegan—affects how their gastr…

This study aims to see if tracking a common inflammation marker (CRP) in the blood can predict how well patients with triple-negative breast cancer respond to immunotherapy. It will observe 225 patients already receiving standard immunotherapy and chemotherapy. The goal is to fin…

This study aims to build a detailed picture of breast cancer by tracking thousands of patients over time. Researchers will collect blood and health data to find markers that predict how the disease progresses and which treatments work best. The goal is to improve future care by u…

This study aims to see if tracking changes in a common inflammation marker (CRP) in the blood can predict how well patients with advanced gynecologic cancers respond to immunotherapy. It will involve 120 women already scheduled to receive standard immunotherapy and chemotherapy. …

This study aims to understand how a woman's menstrual cycle affects breast cancer tumor growth and whether this information, along with genetic tests, helps doctors make better treatment decisions. Researchers will follow 504 women with early-stage, hormone-positive breast cancer…